Sonoma Pharmaceuticals Inc. - שווי שוק בספרים SNOA
Sonoma Pharmaceuticals (SNOA) owns US-based production capacities for hypochlorous acid-based products for medical and veterinary use. Current price action is recorded at 0.01. Steady cash flow is driven by antiseptic sales through pharmacies, confirming the maturity of the assets. However, patent disputes, pricing pressure, and potential difficulties with insurance reimbursements hinder growth.
SNOA (Sonoma Pharma): פילוחים אנליטיים ודוחות לפי אינדיקטורים
Book value capitalization reflects the actual value of net assets minus all liabilities, allowing an investor to determine the intrinsic value of the business and avoid overpaying for an asset. By analyzing the book value capitalization chart of Sonoma Pharmaceuticals (SNOA), one can assess the extent to which the transparency of managing dermatological innovations at Sonoma Pharmaceuticals (SNOA) is supported by sustainable equity growth and the financial stability of management.